Paper6311896
Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC).
McCarley DL and 2 others. J Immunol, 1983. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC). Papers, record 6311896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6311896
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC).
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody-Dependent Cell Cytotoxicity | Major topic |
| Cell Separation | Major topic |
| Monocytes | Major topic |
| Cell Adhesion | |
| Centrifugation | |
| Humans | |
| Leukapheresis | |
| Peroxidase | |
| Receptors, Fc |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01-CA-29266 | NCI NIH HHS | United States | R01CA029266 | PubMed and NIH |
Source NIH RePORTER
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7917934 | m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7917934 | PubMed |
| 7669568 | Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7669568 | PubMed |
| 3918141 | Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. | J Exp Med | 1985 | https://conductscience.org/library/papers/3918141 | PubMed |
| 3350583 | Comparison of human monocytes isolated by elutriation and adherence suggests that heterogeneity may reflect a continuum of maturation/activation states. | Immunology | 1988 | https://conductscience.org/library/papers/3350583 | PubMed |
| 3024880 | Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/3024880 | PubMed |
| 2944818 | Immunological heterogeneity of human monocyte subsets prepared by counterflow centrifugation elutriation. | Immunology | 1986 | https://conductscience.org/library/papers/2944818 | PubMed |
| 2507489 | Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells. | Jpn J Cancer Res | 1989 | https://conductscience.org/library/papers/2507489 | PubMed |
| 2016118 | Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. | Immunology | 1991 | https://conductscience.org/library/papers/2016118 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6311896
GET https://conductscience.org/api/papers/v1/6311896/authors